Skip to main content

PYC taps investors for $75m

14/03/2024 - 16:06

Bookmark

Save articles for future reference.

PYC Therapeutics is rattling the tin for up to $74.6 million to fund the progress of its medical drug trials, including for blinding eye and polycystic kidney diseases.

X

To read our articles you will need to either login or subscribe.